| http://www.w3.org/ns/prov#value | - Whereas the industry???s businessmodel was historically focused on developing drugs to be prescribed in large numbers for common conditions, futurerevenue growth in developed countries like Canada lies primarily in treatments for less common but more seriousconditions.Indeed, data in our Rx Atlas show that spending on specialty drugs to treat conditions such as cancer, HIV, andmultiple sclerosis h
|
